For over a year now, my worldview has been dominated by issues related to mobile healthcare. When you’re in it as deep as I am, it’s easy to lose sight of the fact that, to most folks, this is an entirely new field. And like any new endeavor, there are bound to be mistakes made, and wrong (or at least unproductive) paths followed.

I was reminded of this the other day when I came across the article, Healthcare Marketing Goes Mobile. It prognosticated trends in device usage (smartphones lead the way, with tablets close behind, yawn), but what really caught me was a demographic profile extrapolated from the Pew Internet & American Life Project.

It wasn’t the data itself that concerned me. Instead, it was the idea that one of the wrong paths that mobile healthcare innovators might follow is one of creating products only in response to market research.

Is the best product really an app targeting 25–29 year-old urban black males with some college, making $50k–$75k a year?

Retrospectives of the life of Steve Jobs overflow with delight and admiration for his rare form of innovation. He brought the world products that, until he introduced them, we didn’t know we needed. (I didn’t know I couldn’t live without my iPad until I had one. Now you’d have to pry it from my cold, dead…etc.) Like another super-innovator, Henry Ford opined, “If I had asked people what they wanted, they’d have said ‘faster horses.’”

So the potential mistake I foresee is a company “making faster horses,” in response to polling data. For example, an mHealth developer, acting on the Pew demographic profile, deciding the best product to make is an app specifically targeting 25-29 year old urban black males with some college who make $50k to $75k a year.

I’m definitely not taking the position that market research is useless. My worry is that people will proceed cart-before-horse method and develop apps for a market based on volume (a population responding to a survey) rather than an innovative needs-based (physician/patient insight) concept.

My friend works as a sales rep for a division of Johnson & Johnson selling medical devices. He and I talked about the recent US Senate Panel hearings over possible new FDA regulations for medical device companies advertising directly to consumers.

These regulations would most likely be similar to what is currently required in the pharmaceutical industry.

My guess is that it’s only a matter of time before the medical device industry is required to follow FDA regulations when it comes to DTC ads. (more…)